三七总皂苷联合水飞蓟宾治疗非酒精性脂肪性肝病患者疗效及其对血清细胞因子水平的影响

doi:10.3969/j.issn.1672-5069.2018.04.035

Abstract

Xie Zhanfeng, Jia Jizhen, Zhao Shufang. Combination of notoginseng total saponin and silybin in treatment of patients with non-alcoholic fatty liver diseases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 623-624.

References

[1] Yongxiang Z,Jie H.Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway. Int Immuno,2013,17(3):714-720.
[2] Daniela H,Otilia N.The pathogenesis of non-alcoholic fatty liver disease is closely related to the metabolic syndrome components. Roman J Diabetes Nutrit Metab Dis,2012,19(3):311-321.
[3] 廖文秋,刘小叶,张琍. 多烯磷脂酰胆碱联合水飞蓟宾治疗非酒精性脂肪肝疗效观察. 实用肝脏病杂志,2014,17(2):196-197.
[4] Ahmet S,Ozgur P.Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease. J Pediat Endocrinol Metab,2012,25(10):927-934.
[5] 信丰智,范建高.欧洲非酒精性脂肪性肝病诊疗指南简介. 实用肝脏病杂志,2016,19(4):ⅤⅡ-ⅤⅢ.
[6] YongL,Hye L. Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults. Clin Chem Lab Med,2010,48(2):175-180.
[7] Xuan K,Geli L.Serum vascular endothelial cadherin and thrombomodulin are markers of non-alcoholic fatty liver disease in children. J Pediat Endocrinol Metab,2016,29(12):1331-1335.
[8] 王东霞. 复方甘草酸苷联合中药汤剂治疗非酒精性脂肪肝临床观察. 实用肝脏病杂志,2012,15(2):135-136.
[9] Yusuf Y,Oya Y.Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease. Clin Chem Lab Med,2011,49(1):93-97.
[10] Xinxin Y,Xiaoyu L.Silibinin induced the apoptosis of Hep-2 cells via oxidative stress and down-regulating survivin expression. Eur Arch Oto Rhino Laryngol,2013,270(8):2289-2297.
[11] Yi C,Chang L.Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model. Acta Ophthalmologica,2013,91(7):506-515.
[12] 马欣,顾宏图,赵瑜,等. 不同证候的非酒精性脂肪肝合并肝损伤患者的血清代谢组学分析. 中华中医药杂志,2017,32(3):1246-1250.
[13] Federica S,Pablo A.Rovati. Development and validation of two liquid chromatography-tandem mass spectrometry methods for the determination of silibinin and silibinin hemisuccinate in human plasma. J Chromatogra B,2014,45(9):1-9.
[14] David S,Susan K.Silibinin reverses drug resistance in human small-cell lung carcinoma cells. Cancer Lett,2013,339(1):102-106.
[15] Xiaozhou Y,Liaojun S.Silibinin promotes osteoblast differentiation of human bone marrow stromal cells via bone morphogenetic protein signaling. Eur J Pharmacol,2013,721(1):225-230.

Combination of notoginseng total saponin and silybin in treatment of patients with non-alcoholic fatty liver diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[2]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[3]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[4]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[5]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[6]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[7]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[8]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[9]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[10]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[11]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[12]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[13]	Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663.
[14]	Song Haiyan, Chen Xi, Zhang Junfei, et al. Application of vorionazole in the treatment of patients with liver failure complicated by pulmonary fungal infection [J]. Journal of Practical Hepatology, 2019, 22(5): 676-679.
[15]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.